Unicycive Therapeutics, Inc. (UNCY)
UNCY has a market cap or net worth of $30.54 million. The enterprise value is $12.64 million.
The latest earnings date was Monday, November 15, 2021 before market open.
|Last Earnings Date||Nov 15, 2021|
UNCY has 15.27 million shares outstanding. The number of shares has increased by 66.40% in one year.
|Shares Change (YoY)||+66.40%|
|Shares Change (QoQ)||+61.52%|
|Owned by Insiders (%)||39.61%|
|Owned by Institutions (%)||12.62%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 25.20, with a Debt / Equity ratio of 0.01.
|Debt / Equity||0.01|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||n/a|
|Return on Capital (ROIC)||n/a|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$8.15M|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||-73.92%|
|50-Day Moving Average||2.73|
|200-Day Moving Average||2.81|
|Average Volume (30 Days)||172,208|
Short Selling Information
|Short % of Shares Out||0.46%|
|Short % of Float||1.20%|
|Short Ratio (days to cover)||0.60|
|Earnings Per Share (EPS)||-$0.81|
The company has $18.01 million in cash and $103,000 in debt, giving a net cash position of $17.91 million or $1.17 per share.
|Cash & Cash Equivalents||18.01M|
|Net Cash Per Share||$1.17|
|Book Value Per Share||1.24|
|Operating Cash Flow||n/a|
|Free Cash Flow||n/a|
|FCF Per Share||n/a|
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|